BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35355307)

  • 1. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
    Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
    Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.
    Fenger-Grøn M; Vestergaard CH; Ribe AR; Johnsen SP; Frost L; Sandbæk A; Davydow DS
    JAMA Netw Open; 2021 May; 4(5):e2110096. PubMed ID: 33999163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Gadsbøll K; Staerk L; Fosbøl EL; Sindet-Pedersen C; Gundlund A; Lip GYH; Gislason GH; Olesen JB
    Eur Heart J; 2017 Mar; 38(12):899-906. PubMed ID: 28110293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
    Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.
    Mitchell A; Snowball J; Welsh TJ; Watson MC; McGrogan A
    BMC Med; 2021 Aug; 19(1):189. PubMed ID: 34461899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation.
    Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Salmela B; Kalatsova K; Kouki E; Haukka J; Putaala J; Linna M; Aro AL; Mustonen P; Hartikainen J; Lehto M
    Eur J Clin Invest; 2024 Jan; 54(1):e14107. PubMed ID: 37823410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.
    Maura G; Billionnet C; Drouin J; Weill A; Neumann A; Pariente A
    BMJ Open; 2019 Apr; 9(4):e026645. PubMed ID: 31005934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
    Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
    JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Khurshid S; Weng LC; Hulme OL; Ellinor PT; Lubitz SA
    Am J Cardiol; 2017 Oct; 120(8):1316-1321. PubMed ID: 28823487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
    Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
    J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Giamouzis G; Karvounis H; Tzikas A; Giannakoulas G
    J Thromb Thrombolysis; 2019 Aug; 48(2):225-232. PubMed ID: 30830586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.